Specificity of transcription enhancement via the STAT responsive element in the serine protease inhibitor 2.1 promoter

被引:44
作者
Wood, TJJ
Sliva, D
Lobie, PE
Goullieux, F
Mui, AL
Groner, B
Norstedt, G
Haldosen, LA
机构
[1] PHARMACIA & UPJOHN INC,DEPT CELL BIOL,S-11287 STOCKHOLM,SWEDEN
[2] INST EXPT CANC RES,TUMOR BIOL CTR,D-79106 FREIBURG,GERMANY
[3] DNAX RES INST MOL & CELLULAR BIOL INC,PALO ALTO,CA 94304
关键词
growth hormone; STAT; 5; cytokine;
D O I
10.1016/S0303-7207(97)00075-0
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The growth hormone regulated serine protease inhibitor (SPI) 2.1 and 2.2 gene promoters have been shown to contain a response element similar to the gamma-interferon activated sequence (GAS) family of signal transducer and activator of transcription (STAT) response elements. We have investigated the STAT and cytokine specificity of the SPI 2.1 STAT responsive element using a luciferase (LUG) reporter construct and a cDNA complementation strategy in the COS 7 cell line. Growth hormone was found to stimulate SPI-LUC reporter gene expression via activation of STAT 5, but not STATs 1 or 3, which indicates that the SPI 2.1 STAT responsive element is STAT 5 specific. In addition to the growth hormone receptor, the receptors for prolactin and erythropoietin enhanced gene transcription via the SPI 2.1 STAT responsive element, which indicates that this element is, on the other hand, not cytokine specific. Activation of STAT 5 was also observed after growth hormone treatment of cells transfected with cDNA expression plasmids for several different truncated growth hormone receptor mutants, although this activation was less efficient than with the wild type receptor. Point mutation of individual tyrosines in the growth hormone receptor intracellular domain to phenylalanines had no significant effect on signal transduction via STAT 5. These data, taken together with results from experiments using the phosphatase inhibitor sodium orthovanadate, suggest that STAT 5 may not have an absolute requirement for specific phosphorylated receptor tyrosine docking sites. That receptor tyrosine residues in a variety of amino acid contexts, or phosphorylated Janus kinase (JAK) 2 alone, can facilitate STAT 5 activation could explain the observed lack of cytokine specificity in STAT 5 activation. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:69 / 81
页数:13
相关论文
共 47 条
  • [21] SYNTHESIS OF THE GROWTH HORMONE-REGULATED RAT-LIVER ANTI-PROTEASE GHR-P-63 IS INHIBITED BY ACUTE-INFLAMMATION
    LECAM, G
    LECAM, A
    [J]. FEBS LETTERS, 1987, 210 (01) : 1 - 5
  • [22] CLONING AND EXPRESSION OF STAT5 AND AN ADDITIONAL HOMOLOG (STAT5B) INVOLVED IN PROLACTIN SIGNAL-TRANSDUCTION IN MOUSE MAMMARY TISSUE
    LIU, XW
    ROBINSON, GW
    GOUILLEUX, F
    GRONER, B
    HENNIGHAUSEN, L
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (19) : 8831 - 8835
  • [23] MEYER DJ, 1994, J BIOL CHEM, V269, P4701
  • [24] ONEAL KD, 1994, J BIOL CHEM, V269, P26076
  • [25] PROTEINS OF TRANSCRIPTION FACTOR ISGF-3 - ONE GENE ENCODES THE 91-KDA AND 84-KDA ISGF-3 PROTEINS THAT ARE ACTIVATED BY INTERFERON-ALPHA
    SCHINDLER, C
    FU, XY
    IMPROTA, T
    AEBERSOLD, R
    DARNELL, JE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) : 7836 - 7839
  • [26] INTERFERON REGULATORY FACTOR-I IS INDUCIBLE BY PROLACTIN, INTERLEUKIN-2 AND CONCANAVALIN-A IN T-CELLS
    SCHWARZ, LA
    STEVENS, AM
    HRACHOVY, JA
    YULEE, LY
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1992, 86 (1-2) : 103 - 110
  • [27] SHIU RPC, 1979, CANCER RES, V39, P4381
  • [28] INTERFERON ACTIVATION OF THE TRANSCRIPTION FACTOR STAT91 INVOLVES DIMERIZATION THROUGH SH2-PHOSPHOTYROSYL PEPTIDE INTERACTIONS
    SHUAI, K
    HORVATH, CM
    HUANG, LHT
    QURESHI, SA
    COWBURN, D
    DARNELL, JE
    [J]. CELL, 1994, 76 (05) : 821 - 828
  • [29] STIMULATION OF TYROSINE PHOSPHORYLATION IN HUMAN-CELLS BY ACTIVATION OF THE GROWTH-HORMONE RECEPTOR
    SILVA, CM
    WEBER, MJ
    THORNER, MO
    [J]. ENDOCRINOLOGY, 1993, 132 (01) : 101 - 108
  • [30] SLIVA D, 1994, J BIOL CHEM, V269, P26208